Eva Benavent

579 total citations
21 papers, 242 citations indexed

About

Eva Benavent is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, Eva Benavent has authored 21 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pharmacology and 9 papers in Epidemiology. Recurrent topics in Eva Benavent's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Orthopedic Infections and Treatments (8 papers). Eva Benavent is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Orthopedic Infections and Treatments (8 papers). Eva Benavent collaborates with scholars based in Spain, Australia and Finland. Eva Benavent's co-authors include Óscar Murillo, Javier Ariza, Fé Tubau, Raül Rigo‐Bonnin, Laura Soldevila, Joan Gómez‐Junyent, Alba Ribera, Àlex Soriano, Ariadna Padullés and Xavier Cabo and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Orthopaedics and Related Research and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Eva Benavent

19 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Benavent Spain	9	85	81	80	57	39	21	242
Marion Skalweit United States	9	61 0.7×	87 1.1×	143 1.8×	91 1.6×	33 0.8×	27	291
Wen‐Sen Lee Taiwan	8	23 0.3×	53 0.7×	72 0.9×	100 1.8×	50 1.3×	15	250
Evangelos Vryonis Greece	7	28 0.3×	100 1.2×	190 2.4×	80 1.4×	24 0.6×	11	300
Б. Чарра Morocco	7	18 0.2×	78 1.0×	132 1.6×	73 1.3×	13 0.3×	27	244
Arta Karruli Italy	9	18 0.2×	60 0.7×	106 1.3×	68 1.2×	38 1.0×	18	284
A. Benslama Morocco	6	21 0.2×	81 1.0×	132 1.6×	70 1.2×	11 0.3×	18	230
Alicia Hernández‐Torres Spain	9	38 0.4×	35 0.4×	56 0.7×	78 1.4×	25 0.6×	23	217
Maryann Shango United States	6	26 0.3×	51 0.6×	134 1.7×	98 1.7×	27 0.7×	9	296
S. Hüttner Germany	5	20 0.2×	82 1.0×	46 0.6×	59 1.0×	27 0.7×	8	187
Francesca Cancelli Italy	10	15 0.2×	76 0.9×	65 0.8×	72 1.3×	24 0.6×	20	258

Countries citing papers authored by Eva Benavent

Since Specialization

Citations

This map shows the geographic impact of Eva Benavent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Benavent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Benavent more than expected).

Fields of papers citing papers by Eva Benavent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Benavent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Benavent. The network helps show where Eva Benavent may publish in the future.

Co-authorship network of co-authors of Eva Benavent

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Benavent. A scholar is included among the top collaborators of Eva Benavent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Benavent. Eva Benavent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schenk, H, José Manuel Lomas, Adrian Taylor, et al.. (2025). Risk factors for treatment failure in late acute periprosthetic joint infection in patients with rheumatoid arthritis treated with surgical debridement – a case-control study. Journal of Bone and Joint Infection. 10(4). 217–224.

Benavent, Eva, et al.. (2024). Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm. Antibiotics. 13(4). 344–344.

Benavent, Eva, Marta Ulldemolins, Raül Rigo‐Bonnin, et al.. (2023). Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm. International Journal of Antimicrobial Agents. 62(2). 106856–106856. 8 indexed citations

Benavent, Eva, Oriol Gasch, Dolors Rodríguez-Pardo, et al.. (2023). Vertebral osteomyelitis after spine instrumentation surgery: risk factors and management. Journal of Hospital Infection. 140. 102–109. 5 indexed citations

Núñez-Pereira, Susana, Eva Benavent, Marta Ulldemolins, et al.. (2023). Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study. Antibiotics. 12(3). 518–518. 3 indexed citations

Benavent, Eva, et al.. (2022). Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 60(4). 106664–106664. 7 indexed citations

Ulldemolins, Marta, Eva Benavent, Ariadna Padullés, et al.. (2021). Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection. Antibiotics. 10(4). 446–446. 18 indexed citations

Benavent, Eva, Laura Morata, Francesc Escrihuela-Vidal, et al.. (2021). Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs. Antibiotics. 10(1). 53–53. 21 indexed citations

Wouthuyzen‐Bakker, Marjan, Kaisa Huotari, Eva Benavent, et al.. (2020). Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study. Clinical Orthopaedics and Related Research. 478(6). 1348–1355. 42 indexed citations

10.

Gómez‐Junyent, Joan, Óscar Murillo, Heidi H. Yu, et al.. (2020). In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm. International Journal of Antimicrobial Agents. 57(2). 106246–106246. 10 indexed citations

11.

Gómez‐Junyent, Joan, Raül Rigo‐Bonnin, Eva Benavent, et al.. (2020). Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study. European Journal of Drug Metabolism and Pharmacokinetics. 45(5). 587–599. 5 indexed citations

12.

Gómez‐Junyent, Joan, Eva Benavent, Laura Soldevila, et al.. (2019). Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model. International Journal of Antimicrobial Agents. 53(5). 612–619. 46 indexed citations

13.

Cabellos, Carmen, Iván Pelegrín, Eva Benavent, et al.. (2019). Invasive Meningococcal Disease: What We Should Know, Before It Comes Back. Open Forum Infectious Diseases. 6(3). ofz059–ofz059. 9 indexed citations

14.

Rigo‐Bonnin, Raül, et al.. (2019). Measurement uncertainty of β-lactam antibiotics results: estimation and clinical impact on therapeutic drug monitoring. Clinical Chemistry and Laboratory Medicine (CCLM). 58(2). 240–250. 5 indexed citations

15.

Cabellos, Carmen, Iván Pelegrín, Eva Benavent, et al.. (2019). Impact of pre-hospital antibiotic therapy on mortality in invasive meningococcal disease: a propensity score study. European Journal of Clinical Microbiology & Infectious Diseases. 38(9). 1671–1676. 3 indexed citations

16.

Gómez‐Junyent, Joan, Óscar Murillo, Inmaculada Grau, et al.. (2018). Analysis of mortality in a cohort of 650 cases of bacteremic osteoarticular infections. Seminars in Arthritis and Rheumatism. 48(2). 327–333. 3 indexed citations

17.

Benavent, Eva, Laura Soldevila, & Óscar Murillo. (2018). Protocolo diagnóstico de las infecciones de úlceras del pie diabético. Medicine - Programa de Formación Médica Continuada Acreditado. 12(51). 3048–3051. 1 indexed citations

18.

Rigo‐Bonnin, Raül, Joan Gómez‐Junyent, Eva Benavent, et al.. (2018). Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections. Clinica Chimica Acta. 488. 50–60. 8 indexed citations

19.

Cabellos, Carmen, Iván Pelegrín, Eva Benavent, et al.. (2017). Invasive meningococcal disease: Impact of short course therapy. A DOOR/RADAR study. Journal of Infection. 75(5). 420–425. 8 indexed citations

20.

Ribera, Alba, Eva Benavent, Jaime Lora-Tamayo, et al.. (2015). Osteoarticular infection caused by MDRPseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams. Journal of Antimicrobial Chemotherapy. 70(12). dkv281–dkv281. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact